NATCO PHARMA LTD.
Quaterly Results
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | UnAudited | UnAudited | Audited |
Net Sales | 7586 | 10314 | 11405 | 8979 |
Total Expenditure | 4905 | 5734 | 6125 | 5588 |
PBIDT (Excl OI) | 2681 | 4580 | 5280 | 3391 |
Other Income | 370 | 294 | 197 | 290 |
Operating Profit | 3051 | 4874 | 5477 | 3681 |
Interest | 46 | 42 | 42 | 27 |
Exceptional Items | NA | NA | NA | NA |
PBDT | 3005 | 4832 | 5435 | 3654 |
Depreciation | 442 | 436 | 435 | 410 |
Profit Before Tax | 2563 | 4396 | 5000 | 3244 |
Tax | 436 | 706 | 797 | 486 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | 2127 | 3690 | 4203 | 2758 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | 2127 | 3690 | 4203 | 2758 |
Minority Interest | NA | NA | NA | NA |
Shares of Associates | ||||
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | 2127 | 3690 | 4203 | 2758 |
Equity Capital | 358 | 358 | 358 | 365 |
Face Value (IN RS) | 2 | 2 | 2 | 2 |
Reserves | NA | NA | NA | NA |
Calculated EPS | 11.88 | 20.61 | 23.48 | 15.11 |
Calculated EPS (Annualised) | 47.53 | 82.45 | 93.92 | 60.44 |
No of Public Share Holdings | 90079595 | 90079295 | 89989295 | 93349540 |
% of Public Share Holdings | 50.29 | 50.29 | 50.24 | 51.16 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | 35.34 | 44.40 | 46.29 | 37.76 |
PBIDTM% | 40.21 | 47.25 | 48.02 | 40.99 |
PBDTM% | 39.61 | 46.84 | 47.65 | 40.69 |
PBTM% | 33.78 | 42.62 | 43.84 | 36.12 |
PATM% | 28.03 | 35.77 | 36.85 | 30.71 |
"; | Notes | Notes | Notes | Notes |